SMT201400064B - Procedimento per la produzione di acido 2-[(3,5-difluoro-3'-metossi-1,1'-bifenil-4-il) amino] nicotinico - Google Patents

Procedimento per la produzione di acido 2-[(3,5-difluoro-3'-metossi-1,1'-bifenil-4-il) amino] nicotinico

Info

Publication number
SMT201400064B
SMT201400064B SM201400064T SM201400064T SMT201400064B SM T201400064 B SMT201400064 B SM T201400064B SM 201400064 T SM201400064 T SM 201400064T SM 201400064 T SM201400064 T SM 201400064T SM T201400064 B SMT201400064 B SM T201400064B
Authority
SM
San Marino
Prior art keywords
difluoro
biphenyl
methoxy
amino
production
Prior art date
Application number
SM201400064T
Other languages
English (en)
Italian (it)
Inventor
Bernardini Maria Carmen Boix
Original Assignee
Almirall Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Sa filed Critical Almirall Sa
Publication of SMT201400064B publication Critical patent/SMT201400064B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/803Processes of preparation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SM201400064T 2009-10-16 2014-06-03 Procedimento per la produzione di acido 2-[(3,5-difluoro-3'-metossi-1,1'-bifenil-4-il) amino] nicotinico SMT201400064B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09382212A EP2314577A1 (en) 2009-10-16 2009-10-16 Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid
PCT/EP2010/006283 WO2011045059A1 (en) 2009-10-16 2010-10-14 Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid

Publications (1)

Publication Number Publication Date
SMT201400064B true SMT201400064B (it) 2014-07-07

Family

ID=41402565

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201400064T SMT201400064B (it) 2009-10-16 2014-06-03 Procedimento per la produzione di acido 2-[(3,5-difluoro-3'-metossi-1,1'-bifenil-4-il) amino] nicotinico

Country Status (32)

Country Link
US (1) US8598363B2 (xx)
EP (2) EP2314577A1 (xx)
JP (1) JP5809630B2 (xx)
KR (1) KR101699999B1 (xx)
CN (2) CN103936668A (xx)
AU (1) AU2010306098B2 (xx)
BR (1) BR112012008464B1 (xx)
CA (1) CA2776328C (xx)
CL (1) CL2012000739A1 (xx)
CO (1) CO6430508A2 (xx)
CR (1) CR20120185A (xx)
CY (1) CY1115161T1 (xx)
DK (1) DK2488497T3 (xx)
EA (1) EA022805B1 (xx)
ES (1) ES2467165T3 (xx)
HK (1) HK1168101A1 (xx)
HR (1) HRP20140523T1 (xx)
IL (1) IL218446A (xx)
IN (1) IN2012DN01938A (xx)
ME (1) ME01812B (xx)
MX (1) MX2012004033A (xx)
MY (1) MY160308A (xx)
NZ (1) NZ598429A (xx)
PE (1) PE20121173A1 (xx)
PL (1) PL2488497T3 (xx)
PT (1) PT2488497E (xx)
RS (1) RS53319B (xx)
SI (1) SI2488497T1 (xx)
SM (1) SMT201400064B (xx)
UA (1) UA107811C2 (xx)
WO (1) WO2011045059A1 (xx)
ZA (1) ZA201201563B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2319596B1 (es) 2006-12-22 2010-02-08 Laboratorios Almirall S.A. Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico.
UY31272A1 (es) 2007-08-10 2009-01-30 Almirall Lab Nuevos derivados de ácido azabifenilaminobenzoico
EP2135610A1 (en) * 2008-06-20 2009-12-23 Laboratorios Almirall, S.A. Combination comprising DHODH inhibitors and methotrexate
EP2239256A1 (en) 2009-03-13 2010-10-13 Almirall, S.A. Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor
JP7343373B2 (ja) * 2019-12-02 2023-09-12 花王株式会社 香料組成物

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9608997A (pt) 1995-06-21 1999-06-29 Asta Medica Ag Cartucho para pó farmacêutico com dispositivo de medição integrado e intalador para medicamentos em pó
DE19547648A1 (de) 1995-12-20 1997-06-26 Hoechst Ag Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate
DE19610955A1 (de) 1996-03-20 1997-09-25 Hoechst Ag Kombinationspräparat, enthaltend 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)- anilid und N-(4-Trifluormethylphenyl)-2-cyan-3- hydroxycrotonsäureamid
GB9804343D0 (en) 1998-02-27 1998-04-22 Univ Cardiff Chemical compounds
JP2003504310A (ja) 1999-06-10 2003-02-04 ワーナー−ランバート・カンパニー アミロイドタンパク質凝集阻害方法およびアミロイド沈着物の画像化方法
AR033459A1 (es) 2001-04-05 2003-12-17 Aventis Pharma Inc Uso de (41-trifluorometilfenil)-amida del acido (z)-2-ciano-3-hidroxi-but-2-enoico para el tratamiento de la esclerosis multiple
WO2002102374A1 (en) 2001-06-19 2002-12-27 Merck & Co., Inc. Amine salt of an integrin receptor antagonist
DE10129703A1 (de) 2001-06-22 2003-01-02 Sofotec Gmbh & Co Kg Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren
WO2003006424A1 (en) 2001-07-10 2003-01-23 4Sc Ag Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
US7258118B2 (en) 2002-01-24 2007-08-21 Sofotec Gmbh & Co, Kg Pharmaceutical powder cartridge, and inhaler equipped with same
DE10202940A1 (de) 2002-01-24 2003-07-31 Sofotec Gmbh & Co Kg Patrone für einen Pulverinhalator
BR0307557A (pt) * 2002-02-13 2005-01-04 Glaxo Group Ltd Derivados benzenosulfonamida como agentes antipsicóticos
US20070135488A1 (en) * 2002-04-13 2007-06-14 Chung You S Amlodipine nicotinate and process for the preparation thereof
PE20040844A1 (es) * 2002-11-26 2004-12-30 Novartis Ag Acidos fenilaceticos y derivados como inhibidores de la cox-2
EP1581478A1 (en) 2002-12-23 2005-10-05 4Sc Ag Dhodh-inhibitors and method for their identification
WO2004056746A1 (en) 2002-12-23 2004-07-08 4Sc Ag Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
SE0400234D0 (sv) 2004-02-06 2004-02-06 Active Biotech Ab New compounds, methods for their preparation and use thereof
EP1763346A4 (en) 2004-05-21 2009-03-04 Uab Research Foundation COMPOSITION AND METHODS RELATING TO INHIBITORS OF PYRIMIDINE SYNTHESIS
WO2006022442A1 (ja) 2004-08-24 2006-03-02 Santen Pharmaceutical Co., Ltd. ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体
BRPI0518205A (pt) 2004-10-19 2008-11-04 Aventis Pharma Inc uso de (4'-trifluorometilfenil)-amida de ácido (z)-2-ciano-3-hidróxi-but-2-enóico para o tratamento de doença inflamatória do intestino
ES2265276B1 (es) 2005-05-20 2008-02-01 Laboratorios Almirall S.A. Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.
CN1696100B (zh) * 2005-06-01 2010-11-24 黑龙江福和华星制药集团股份有限公司 痤疮治疗药阿达帕林的新型简捷合成方法
ES2319596B1 (es) 2006-12-22 2010-02-08 Laboratorios Almirall S.A. Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico.
WO2008097180A1 (en) 2007-02-06 2008-08-14 Chelsea Therapeutics, Inc. New compounds, methods for their preparation and use thereof
UY31272A1 (es) 2007-08-10 2009-01-30 Almirall Lab Nuevos derivados de ácido azabifenilaminobenzoico
EP2135610A1 (en) 2008-06-20 2009-12-23 Laboratorios Almirall, S.A. Combination comprising DHODH inhibitors and methotrexate
EP2210615A1 (en) 2009-01-21 2010-07-28 Almirall, S.A. Combinations comprising methotrexate and DHODH inhibitors
EP2239256A1 (en) 2009-03-13 2010-10-13 Almirall, S.A. Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor
EP2228367A1 (en) 2009-03-13 2010-09-15 Almirall, S.A. Addition salts of amines containing hydroxyl and/or carboxylic groups with amino nicotinic acid derivatives as DHODH inhibitors
EP2230232A1 (en) 2009-03-13 2010-09-22 Almirall, S.A. Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as DHODH inhibitors

Also Published As

Publication number Publication date
KR101699999B1 (ko) 2017-01-26
WO2011045059A1 (en) 2011-04-21
EP2488497A1 (en) 2012-08-22
AU2010306098B2 (en) 2015-10-15
EP2488497B1 (en) 2014-03-12
EA022805B1 (ru) 2016-03-31
DK2488497T3 (da) 2014-06-10
CL2012000739A1 (es) 2012-10-12
RS53319B (en) 2014-10-31
PL2488497T3 (pl) 2014-07-31
IN2012DN01938A (xx) 2015-08-21
BR112012008464A2 (pt) 2015-09-22
PT2488497E (pt) 2014-05-28
MY160308A (en) 2017-02-28
PE20121173A1 (es) 2012-08-30
CO6430508A2 (es) 2012-04-30
EP2314577A1 (en) 2011-04-27
US20120245359A1 (en) 2012-09-27
US8598363B2 (en) 2013-12-03
CR20120185A (es) 2012-06-11
AU2010306098A1 (en) 2012-03-15
JP2013507407A (ja) 2013-03-04
CY1115161T1 (el) 2016-12-14
IL218446A0 (en) 2012-04-30
EA201200594A1 (ru) 2012-11-30
CN103936668A (zh) 2014-07-23
NZ598429A (en) 2014-02-28
JP5809630B2 (ja) 2015-11-11
CN102574800A (zh) 2012-07-11
CA2776328C (en) 2017-08-08
MX2012004033A (es) 2012-05-08
CA2776328A1 (en) 2011-04-21
BR112012008464B1 (pt) 2021-08-24
ME01812B (me) 2014-09-20
HRP20140523T1 (hr) 2014-07-04
ES2467165T3 (es) 2014-06-12
KR20120087131A (ko) 2012-08-06
HK1168101A1 (en) 2012-12-21
CN102574800B (zh) 2014-09-17
UA107811C2 (en) 2015-02-25
IL218446A (en) 2014-08-31
SI2488497T1 (sl) 2014-08-29
ZA201201563B (en) 2012-11-28

Similar Documents

Publication Publication Date Title
IT1401911B1 (it) Processo per la sintesi di acido 2,5-furandicarbossilico
HK1204960A1 (en) Process for the production of 2-[4-(3- or 2- fluorobenzyloxy)benzylamino]propanami[with high purity degree 2-[4-(3- 2-)]
BRPI0905928A2 (pt) "método de produção de ácido lático"
SMT201600206B (it) Processo per la produzione di intermedi dell'estetrolo
BRPI0811828A2 (pt) "método de produção de ácido lático"
BRPI1015062A2 (pt) "processo para preparar ácido fórmico"
PL2352386T3 (pl) Sposób wytwarzania związku kwasu n-masłowego w postaci mikrokapsułkowanej do spożycia przez zwierzęta lub ludzi
HRP20130456T1 (xx) Novi postupak za dobivanje derivata aminokiseline
BRPI1014326A2 (pt) metodo continuo para producao de amidas de acidos carboxilicos alifaticos
EP2297079A4 (en) PROCESS FOR PRODUCING GLYCOLIC ACID
SMT201400064B (it) Procedimento per la produzione di acido 2-[(3,5-difluoro-3'-metossi-1,1'-bifenil-4-il) amino] nicotinico
EP2264144A4 (en) PROCESS FOR THE PREPARATION OF 5'-GUANYLIC ACID
IT1394503B1 (it) Sali di 6'-sialillattosio e processo per la loro sintesi e per la sintesi di altri alfa-sialiloligosaccaridi.
IL205745A0 (en) Method for the production of 2-fluoroacyl-3-amino-acrylic acid derivatives
BR112012025490A2 (pt) ''método para produção de 1,5 oebtanodiamina''
BR112012017828A2 (pt) ''método para a produção de um produto químico por fermentação contínua''
IL207431A0 (en) New process for the preparation of cyclohexanecarboxylic acid derivatives
FR2947265B1 (fr) Procede de preparation d'alkylalcanolamines
BRPI1012007A2 (pt) "método para a preparação de ácido 2-ceto-carboxílico"
IT1396172B1 (it) Procedimento integrato per la produzione di idrogeno da acido solfidrico
IT1394296B1 (it) Metodo di sintesi dell'acido glicocolico.
FR2974804B1 (fr) Procede de preparation d'un acide glycolique de haute purete
IT1393095B1 (it) Processo per la sintesi del sale disodico dell'acido ursodesossicolico 3,7-disolfato.
IT1400485B1 (it) Nuovo processo per la preparazione dell'aminaftone
BR112012029363A2 (pt) 'método para produção de 1-alquil-3-difluormetil-5-hidroxipirazóis'